Niva Bupa Health Insurance Company Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Niva Bupa has filed its quarterly compliance statement under SEBI Regulation 32 regarding the use of proceeds from its November 2024 IPO. The company raised gross proceeds of INR 800 crores, earmarked for augmenting its capital base to maintain and strengthen solvency levels. The full amount of INR 800 crores has been utilised for the stated object during the quarter, with no deviation or variation reported. The statement was reviewed by the Audit Committee on November 3, 2025 and signed by CFO Vishwanath Mahendra. No monitoring agency was applicable for this issue.
This is a routine compliance filing and a neutral-to-positive signal — it confirms the company has used its entire IPO proceeds exactly as promised to investors, with no diversion of funds. Shareholders can take comfort from the disciplined deployment of capital towards solvency strengthening, though there is no new fundamental trigger for the stock.